INTRODUCE
Sinopharm animal health Co., Ltd. (hereinafter referred to as "SPAH") was founded in 1971. Its predecessor is Hubei veterinary biological pharmaceutical factory. It is a national high-tech enterprise specializing in the research, development, production and sales of animal health products and a national major animal disease vaccine targeted production enterprise. It is now the backbone enterprise of China Biotechnology Co., Ltd. under the world top 500 China Pharmaceutical Group Co., Ltd.
The company has two production bases in Wuhan Jiulong and Yangzhou Hanjiang and Wuhan Fenghuang experimental animal base. It can produce more than 60 animal biological products in six categories, including pig vaccines, poultry vaccines, cattle and sheep vaccines, pet vaccines, economic animal vaccines and diagnostic and therapeutic products. With an annual production capacity of more than 10 billion birds (heads), it is one of the animal biological products enterprises with the most complete variety of pig vaccines in China.
The company has built many innovative platforms such as China biological animal health research and development center, Hubei animal biological products research and development center, Jiangsu animal vaccine Engineering Technology Research Center, etc. the level of baculovirus expression technology, cell suspension culture technology, antigen concentration and purification technology and high-throughput disease diagnosis technology is leading in China, and has accumulated outstanding capabilities in product research and development, technological innovation, agricultural scientific and technological achievements transformation, etc, It is one of the few animal health enterprises in China with the original ability of new products.
The company advocates the concept of "service marketing", promotes the integrated service of "program door-to-door, door-to-door delivery, immunization door-to-door, and monitoring door-to-door", implements the marketing mode of "one county, one generation, one service, one company, one policy", and the sales service network covers the livestock and poultry breeding areas in the country. The market share of many products such as porcine circovirus type 2 baculovirus vector inactivated vaccine (cp08 strain) ranks among the forefront of the industry.
After years of struggle, the company has formed a specialized, refined and plate-based business pattern of animal health industry, and shoulders the central enterprise mission of preventing and controlling animal epidemics and ensuring human health. The company will continue to adhere to the concept of "caring for life and caring for health" and take the mission of "healthy animals and healthy humans" as its mission, and strive to become a leading enterprise in the domestic veterinary biological products industry.
CONTACT US
ADDRESS: building A21, biological innovation park, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province
Copyright © Sinopharm Animal Health Corporation Ltd. All Rights Reserved. SEO Powered by 300.cn